Share-based Compensation	3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Share-based Compensation	Share-based Compensation During the three months ended March 31, 2026, we granted 0.08 restricted stock units. The total fair value of awards granted to employees during the three months ended March 31, 2026 was $17.0. In addition, our non-employee directors received stock awards with a total fair value of $0.3. Stock options generally have a 4-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the three months ended March 31, 2026, 0.05 restricted stock and restricted stock units vested, and 0.03 performance units vested. Share-based compensation expense was $5.4 and $6.2 for the three months ended March 31, 2026 and 2025, respectively. Share-based compensation expense is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of operations and comprehensive (loss) income. As of March 31, 2026, total share-based compensation of $25.1 is expected to be recognized over the weighted-average period of approximately 2.1 years.

Share-based Compensation

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement, Noncash Expense [Abstract]

During the three months ended March 31, 2026, we granted 0.08 restricted stock units. The total fair value of awards granted to employees during the three months ended March 31, 2026 was $17.0. In addition, our non-employee directors received stock awards with a total fair value of $0.3.

Stock options generally have a 4-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the three months ended March 31, 2026, 0.05 restricted stock and restricted stock units vested, and 0.03 performance units vested.

Share-based compensation expense was $5.4 and $6.2 for the three months ended March 31, 2026 and 2025, respectively. Share-based compensation expense is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of operations and comprehensive (loss) income. As of March 31, 2026, total share-based compensation of $25.1 is expected to be recognized over the weighted-average period of approximately 2.1 years.